Alpha Tau Medical (DRTS) Receivables - Other (2020 - 2025)

Alpha Tau Medical has reported Receivables - Other for 6 years, with the latest figure at $36000.0 in Q4 2025.

• Quarterly Receivables - Other rose 111.76% year-over-year to $36000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $36000.0 (up 111.76% YoY) and the FY2025 annual result came in at $36000.0, up 111.76% from the prior year.
• Receivables - Other advanced to $36000.0 in Q4 2025 per DRTS's latest filing, from $17000.0 in the prior quarter.
• Over five years, Receivables - Other peaked at $36000.0 in Q4 2025 and troughed at $17000.0 in Q4 2024.
• A 5-year average of $25200.0 and a median of $22000.0 in 2021 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2021 and 2023: Receivables - Other jumped 340.0% in 2021, then plunged 40.62% in 2023.
• Over 5 years, Receivables - Other stood at $22000.0 in 2021, then jumped by 45.45% to $32000.0 in 2022, then slumped by 40.62% to $19000.0 in 2023, then slipped by 10.53% to $17000.0 in 2024, then soared by 111.76% to $36000.0 in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered $36000.0, $17000.0, and $19000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.